BLOG

Friday, December 20, 2019

Karuna Therapeutics, little-known firm is yr's best US IPO with 420% surge

Early Karuna holders saw more than 420 per cent returns since the June IPO at $16 a share

from Home Page https://ift.tt/372Vlo5
via IFTTT

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...